Morgan Stanley’s CollPlant Biotechnologies CLGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 8064 |
|
|
2025
Q1 | $4 | Hold |
1
| – | – | ﹤0.01% | 8039 |
|
|
2024
Q4 | $6 | Hold |
1
| – | – | ﹤0.01% | 7923 |
|
|
2024
Q3 | $8 | Hold |
1
| – | – | ﹤0.01% | 7874 |
|
|
2024
Q2 | $8 | Hold |
1
| – | – | ﹤0.01% | 7790 |
|
|
2024
Q1 | $9 | Sell |
1
-1
| -50% | -$9 | ﹤0.01% | 7773 |
|
|
2023
Q4 | $24 | Sell |
2
-119
| -98% | -$1.43K | ﹤0.01% | 7748 |
|
|
2023
Q3 | $674 | Hold |
121
| – | – | ﹤0.01% | 7275 |
|
|
2023
Q2 | $987 | Sell |
121
-50
| -29% | -$408 | ﹤0.01% | 7295 |
|
|
2023
Q1 | $1.2K | Hold |
171
| – | – | ﹤0.01% | 7326 |
|
|
2022
Q4 | $1.43K | Sell |
171
-2
| -1% | -$17 | ﹤0.01% | 7419 |
|
|
2022
Q3 | $1K | Buy |
173
+123
| +246% | +$711 | ﹤0.01% | 7550 |
|
|
2022
Q2 | $0 | Sell |
50
-200
| -80% | – | ﹤0.01% | 7825 |
|
|
2022
Q1 | $3K | Sell |
250
-471
| -65% | -$5.65K | ﹤0.01% | 7676 |
|
|
2021
Q4 | $12K | Buy |
721
+671
| +1,342% | +$11.2K | ﹤0.01% | 7407 |
|
|
2021
Q3 | $1K | Sell |
50
-100
| -67% | -$2K | ﹤0.01% | 7758 |
|
|
2021
Q2 | $3K | Buy |
+150
| New | +$3K | ﹤0.01% | 7480 |
|